Diabetes Prevention and Intervention: Conflict between Public Health and Individual Autonomy
Keywords:
MedicineReferences
1. World Health Organization (WHO). Definition, diagnosis and classification of diabetes mellitus and its complications.Report of a WHO Consulta- tion. Geneva: WHO, 1999.
2. Concannon P, Rich SS, Nepom GT. Genetics of type 1A diabetes. N Engl J med 2009; 360: 1646 – 1654.
3. International Diabetes Federation. IDF Diabetes Atlas Fifth Edition. Available from: http://www.idf. org/diabetesatlas/5e/the-global-burden
4. Anderson RJ, Freedland KE, Clouse RE, Lust- man PJ. The prevalence of comorbid depression in adults with diabetes: a meta-analysis. Diabetes Care 2001;24(6):1069 – 1078.
5. Li C et al. Diabetes and anxiety in US adults: find- ings from the 2006 Behavioural Risk Factor Surveil- lance System. Diabet. Med. 2008; 25(7): 878-881.
6. Engstrom I et al.Eating disorders in adolescent girls with insulin-dependent diabetes mellitus: a population-based case-control study. Acta Paedi- atr.1999 ;88(2):175 -180.
7. Chaoyang Li et al. Association between diag- nosed diabetes and serious psychological distress among U.S. adults: the Behavioural Risk Factor Surveillance System,2007. Int J Public Health 2009, 54 Suppl 1:43-51
8. Diabetes Federation Of Ireland 2011.Diabetes Action. Numbers with diabetes climb to over 191,000 following censs results.Available from: http://www.diabetesaction.ie/news/2011/10/ numbers-with-diabetes-climb-following-census- results/32
9. VHI Healthcare. Ireland’s Largest Screening Project Warns of High Incidence of Un-detected Diabetes. 2011. Available from: https://www.vhi. ie/personalise/controller/PrItemDisplay?PRYear=2 011&prId=18
10. Nolan JJ, O’Halloran D, McKenna TJ, Firth R, Redmond S. The cost of treating type 2 diabetes (CODEIRE). Ir Med J. 2006 Nov-Dec;. 99(10):307- 10.
11. WHO. Diabetes Programme. Country and regional data on diabetes. Availabile from http:// www.who.int/diabetes/facts/world_figures/en/ index4.html
12. E. L. Lim et al. Reversal of type 2 diabetes: normalisation of beta cell function in association with decreased pancreas and liver triacylglycerol. Diabetologia 2011, 54(10): 2506–2514.
13. Gillen JB et al. Acute high-intensity interval exercise reduces the postprandial glucose response and prevalence of hyperglycemia in patients with type 2 diabetes. Diabetes Obes Metab. 2012 Jan 23. doi: 10.1111/j.1463-1326.2012.01564.x. [Epub ahead of print]
14. Stratton IM et al.Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observa-
tional study. BMJ 2000 Aug 12;321(7208): 405-
15. Ribu L, Hanestad BR, Moum T, Birkeland K, Rus- toen T. A comparison of the health-related quality of life in patients with diabetic foot ulcers, with a diabetes group and a nondiabetes group from the general population. Qual Life Res. 2007;16(2):179- 89.
16. Mayfield JA, Deb P, Whitecotton L.Work disabil- ity and diabetes. Diabetes Care 1999; 22(7):1105- 1109
17. Nolan JJ, O’Halloran D, McKenna TJ, Firth R, Redmond S. The cost of treating type 2 diabetes (CODEIRE). Ir Med J. 2006 Nov-Dec;. 99(10):307- 10.
18. Dworkin, G. Paternalism. The Monist 1972; 56:64-84.
19. Gray J (ed). Mill JS. On Liberty and other es- says. Oxford. Oxford University Press; [1859]/ (1991)
20. Childress JF et al. Public health ethics: mapping the terrain. J Law Med Ethics 2002 Summer; 30 (2):170-8. Sent!
21. Marmot MG. Understanding social inequalities in health. Perspect Biol Med. 2003; 46(3 Suppl):S9- S23.
22. Marmot, M. Social causes of social inequalities in health. [book auth.] Peter F., Sen A. Anand S. eds Public Health, Ethics, and Equity. Oxford: Oxford University Press; 2004.
23. Marmot M., Wilkinson RG. Social Determinants of Health. New York: Oxford University Press; 1999.
24. Jacobson v Massachusetts. 197, s.l.: US 11, 25 S.Ct. 358 (1905) Available from: http://biotech.law. lsu.edu/cases/vaccines/Jacobson_v_Massachu- setts.htm
25. Omran AR. The Epidemiologic Transition: A Theory of the Epidemiology of Population Change. Milbank Mem Fund Q. 1971; 49(4): 509–538.
26. Skrabanek, P.. Why is preventative medicine exempted from ethical constraints? J Med al Ethics 1990; 16(4):187-190.
27. Keen JD, Keen JE. What is the point: will screen- ing mammography save my life?BMC Med Inform Decis Mak. 2009 Apr 2;9:18.
28. Baxter N, Canadian Task Force on Preventive Health Care, 2001 update: should women be rou- tinely taught breast self-examination to screen for breast cancer? CMAJ. 2001 Jun 26;164(13):1837- 46.
29. Stoate HG. Can health screening damage your health? J R Coll Gen pract. 1989 May; 39(322):193- 195.
2. Concannon P, Rich SS, Nepom GT. Genetics of type 1A diabetes. N Engl J med 2009; 360: 1646 – 1654.
3. International Diabetes Federation. IDF Diabetes Atlas Fifth Edition. Available from: http://www.idf. org/diabetesatlas/5e/the-global-burden
4. Anderson RJ, Freedland KE, Clouse RE, Lust- man PJ. The prevalence of comorbid depression in adults with diabetes: a meta-analysis. Diabetes Care 2001;24(6):1069 – 1078.
5. Li C et al. Diabetes and anxiety in US adults: find- ings from the 2006 Behavioural Risk Factor Surveil- lance System. Diabet. Med. 2008; 25(7): 878-881.
6. Engstrom I et al.Eating disorders in adolescent girls with insulin-dependent diabetes mellitus: a population-based case-control study. Acta Paedi- atr.1999 ;88(2):175 -180.
7. Chaoyang Li et al. Association between diag- nosed diabetes and serious psychological distress among U.S. adults: the Behavioural Risk Factor Surveillance System,2007. Int J Public Health 2009, 54 Suppl 1:43-51
8. Diabetes Federation Of Ireland 2011.Diabetes Action. Numbers with diabetes climb to over 191,000 following censs results.Available from: http://www.diabetesaction.ie/news/2011/10/ numbers-with-diabetes-climb-following-census- results/32
9. VHI Healthcare. Ireland’s Largest Screening Project Warns of High Incidence of Un-detected Diabetes. 2011. Available from: https://www.vhi. ie/personalise/controller/PrItemDisplay?PRYear=2 011&prId=18
10. Nolan JJ, O’Halloran D, McKenna TJ, Firth R, Redmond S. The cost of treating type 2 diabetes (CODEIRE). Ir Med J. 2006 Nov-Dec;. 99(10):307- 10.
11. WHO. Diabetes Programme. Country and regional data on diabetes. Availabile from http:// www.who.int/diabetes/facts/world_figures/en/ index4.html
12. E. L. Lim et al. Reversal of type 2 diabetes: normalisation of beta cell function in association with decreased pancreas and liver triacylglycerol. Diabetologia 2011, 54(10): 2506–2514.
13. Gillen JB et al. Acute high-intensity interval exercise reduces the postprandial glucose response and prevalence of hyperglycemia in patients with type 2 diabetes. Diabetes Obes Metab. 2012 Jan 23. doi: 10.1111/j.1463-1326.2012.01564.x. [Epub ahead of print]
14. Stratton IM et al.Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observa-
tional study. BMJ 2000 Aug 12;321(7208): 405-
15. Ribu L, Hanestad BR, Moum T, Birkeland K, Rus- toen T. A comparison of the health-related quality of life in patients with diabetic foot ulcers, with a diabetes group and a nondiabetes group from the general population. Qual Life Res. 2007;16(2):179- 89.
16. Mayfield JA, Deb P, Whitecotton L.Work disabil- ity and diabetes. Diabetes Care 1999; 22(7):1105- 1109
17. Nolan JJ, O’Halloran D, McKenna TJ, Firth R, Redmond S. The cost of treating type 2 diabetes (CODEIRE). Ir Med J. 2006 Nov-Dec;. 99(10):307- 10.
18. Dworkin, G. Paternalism. The Monist 1972; 56:64-84.
19. Gray J (ed). Mill JS. On Liberty and other es- says. Oxford. Oxford University Press; [1859]/ (1991)
20. Childress JF et al. Public health ethics: mapping the terrain. J Law Med Ethics 2002 Summer; 30 (2):170-8. Sent!
21. Marmot MG. Understanding social inequalities in health. Perspect Biol Med. 2003; 46(3 Suppl):S9- S23.
22. Marmot, M. Social causes of social inequalities in health. [book auth.] Peter F., Sen A. Anand S. eds Public Health, Ethics, and Equity. Oxford: Oxford University Press; 2004.
23. Marmot M., Wilkinson RG. Social Determinants of Health. New York: Oxford University Press; 1999.
24. Jacobson v Massachusetts. 197, s.l.: US 11, 25 S.Ct. 358 (1905) Available from: http://biotech.law. lsu.edu/cases/vaccines/Jacobson_v_Massachu- setts.htm
25. Omran AR. The Epidemiologic Transition: A Theory of the Epidemiology of Population Change. Milbank Mem Fund Q. 1971; 49(4): 509–538.
26. Skrabanek, P.. Why is preventative medicine exempted from ethical constraints? J Med al Ethics 1990; 16(4):187-190.
27. Keen JD, Keen JE. What is the point: will screen- ing mammography save my life?BMC Med Inform Decis Mak. 2009 Apr 2;9:18.
28. Baxter N, Canadian Task Force on Preventive Health Care, 2001 update: should women be rou- tinely taught breast self-examination to screen for breast cancer? CMAJ. 2001 Jun 26;164(13):1837- 46.
29. Stoate HG. Can health screening damage your health? J R Coll Gen pract. 1989 May; 39(322):193- 195.
Downloads
Published
2012-01-01
How to Cite
Crowe, G. (2012). Diabetes Prevention and Intervention: Conflict between Public Health and Individual Autonomy. Trinity Student Medical Journal , 13(1), Page 17–19. Retrieved from https://ojs.tchpc.tcd.ie/index.php/tsmj/article/view/1810
Issue
Section
Features
License
Authors retain copyright and grant the journal the right of first publication with the work simultaneously licensed under a Creative Commons Attribution (CC-BY) 4.0 License that allows others to share the work with an acknowledgement of the work’s authorship and initial publication in this journal.
Provided they are the owners of the copyright to their work, authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal’s published version of the work (e.g., post it to an institutional repository, in a journal or publish it in a book), with an acknowledgement of its initial publication in this journal.
